Review



myriapod brca 1–2 panel  (Diatech Pharmacogenetics)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Diatech Pharmacogenetics myriapod brca 1–2 panel
    Myriapod Brca 1–2 Panel, supplied by Diatech Pharmacogenetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myriapod+brca+1%E2%80%932+panel/myriapod+ngs+cancer+panel+dna/pmc12166786-32-17-21
    Average 90 stars, based on 1 article reviews
    myriapod brca 1–2 panel - by Bioz Stars, 2026-10
    90/100 stars

    Images

    Related Articles

    Next-Generation Sequencing:

    Article Title: BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient
    Article Snippet: Mutational status analysis of BRCA1/2 and PALB2 on tumor tissues was performed by next-generation sequencing using the Myriapod BRCA 1–2 panel (Diatech Pharmacogenetics srl, Jesi, AN, Italy) run on an Illumina MiSeq sequencing platform (Illumina Inc., San Diego, CA, US), and using a Myriapod NGS Data Analysis Software (v.5; Diatech Pharmacogenetics) for bioinformatics analysis.

    Sequencing:

    Article Title: BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient
    Article Snippet: Mutational status analysis of BRCA1/2 and PALB2 on tumor tissues was performed by next-generation sequencing using the Myriapod BRCA 1–2 panel (Diatech Pharmacogenetics srl, Jesi, AN, Italy) run on an Illumina MiSeq sequencing platform (Illumina Inc., San Diego, CA, US), and using a Myriapod NGS Data Analysis Software (v.5; Diatech Pharmacogenetics) for bioinformatics analysis.

    Software:

    Article Title: BRAF V600E mutation associated with papillary high-grade serous ovarian cystadenocarcinoma in a 22q11.2DS patient
    Article Snippet: Mutational status analysis of BRCA1/2 and PALB2 on tumor tissues was performed by next-generation sequencing using the Myriapod BRCA 1–2 panel (Diatech Pharmacogenetics srl, Jesi, AN, Italy) run on an Illumina MiSeq sequencing platform (Illumina Inc., San Diego, CA, US), and using a Myriapod NGS Data Analysis Software (v.5; Diatech Pharmacogenetics) for bioinformatics analysis.



    Similar Products

    myriapod brca 1–2 panel  (Diatech Pharmacogenetics)
    90
    Diatech Pharmacogenetics myriapod brca 1–2 panel
    Myriapod Brca 1–2 Panel, supplied by Diatech Pharmacogenetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myriapod+brca+1%E2%80%932+panel/myriapod+ngs+cancer+panel+dna/pmc12166786-32-17-21
    Average 90 stars, based on 1 article reviews
    myriapod brca 1–2 panel - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    myriapod ngs-lt brca 1–2 panel  (Diatech Pharmacogenetics)
    90
    Diatech Pharmacogenetics myriapod ngs-lt brca 1–2 panel
    Myriapod Ngs Lt Brca 1–2 Panel, supplied by Diatech Pharmacogenetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/myriapod+brca+1%E2%80%932+panel/myriapod+ngs+cancer+panel+dna/pmc08946832-112-18-23
    Average 90 stars, based on 1 article reviews
    myriapod ngs-lt brca 1–2 panel - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results